Nothing Special   »   [go: up one dir, main page]

AR241713A1 - Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe. - Google Patents

Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.

Info

Publication number
AR241713A1
AR241713A1 AR85301435A AR30143585A AR241713A1 AR 241713 A1 AR241713 A1 AR 241713A1 AR 85301435 A AR85301435 A AR 85301435A AR 30143585 A AR30143585 A AR 30143585A AR 241713 A1 AR241713 A1 AR 241713A1
Authority
AR
Argentina
Prior art keywords
influenza
preparing
amino acids
protein
molecula
Prior art date
Application number
AR85301435A
Other languages
English (en)
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Application granted granted Critical
Publication of AR241713A1 publication Critical patent/AR241713A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

UNA MOLECULA DE DNA QUE COMPRENDE UNA SECUENCIA DE BASES QUE CODIFICA LA PROTEINA C13, UTIL PARA PREPARAR VACUNAS CONTRA LA GRIPE, DONDE LA MOLECULA DE DNA COMPRENDE LA SECUENCIA CODIFICANTE DELOS 81 AMINOACIDOS N-TERMIANLES DE LA FEOTEINA NS1 FUSIONADA VIA LA SECUENCIA -ASP-LEU- A LOS DOS ULTIMOS AMINOACIDOS (-SER-ARG) DE HA1, PROCEDIMIENTO PARA PREPARAR UNA VACUNA CONTRA INFECCIONESDEBIDAS AL VIRUS DE LA GRIPE QUE COMBINA LA PROTEINA C13, OBTENIDA POR EXPRESION DEL VECTOR C13, EN LA CEPA 5151 DE E. COLI Y UN VEHICULO FARMACOLOGICAMENTE ACEPTABLE.
AR85301435A 1984-08-30 1985-08-08 Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe. AR241713A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64573284A 1984-08-30 1984-08-30

Publications (1)

Publication Number Publication Date
AR241713A1 true AR241713A1 (es) 1992-11-30

Family

ID=24590246

Family Applications (1)

Application Number Title Priority Date Filing Date
AR85301435A AR241713A1 (es) 1984-08-30 1985-08-08 Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.

Country Status (20)

Country Link
EP (1) EP0176493B1 (es)
JP (1) JPS6169731A (es)
KR (1) KR860001882A (es)
AR (1) AR241713A1 (es)
AT (1) ATE63462T1 (es)
AU (1) AU592954B2 (es)
DE (1) DE3582843D1 (es)
DK (1) DK389085A (es)
ES (1) ES8800358A1 (es)
FI (1) FI85811C (es)
GR (1) GR852079B (es)
HU (1) HU196131B (es)
IE (1) IE58488B1 (es)
IL (1) IL76236A0 (es)
NO (1) NO169819C (es)
NZ (1) NZ213249A (es)
PH (1) PH27147A (es)
PT (1) PT81061B (es)
ZA (1) ZA856467B (es)
ZW (1) ZW13485A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803072A (en) * 1986-09-10 1989-02-07 Smithkline Beckman Corporation Immunomodulation
NZ219515A (en) * 1987-02-10 1989-09-27 Wellcome Found Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
AU640348B2 (en) * 1988-08-31 1993-08-26 Smithkline Beecham Corporation Vaccinal Polypeptides
DK425789A (da) * 1988-08-31 1990-03-01 Smithkline Beecham Corp Vaccinale polypeptider
ZA896625B (en) * 1988-08-31 1990-09-26 Smithkline Beecham Corp Vaccinal polypeptides
DE69123252T2 (de) * 1990-08-08 1997-03-13 University Of Massachusetts Medical Center, Worcester, Mass. Kreuzreaktive immunisierung gegen influenza
US5766601A (en) * 1990-08-08 1998-06-16 University Of Massachusetts Medical Center Cross-reactive influenza a immunization
WO1994022917A1 (en) * 1993-04-05 1994-10-13 University Of Massachusetts Medical Center Cross-reactive influenza a immunization
SI1659179T1 (sl) 1998-02-05 2011-10-28 Glaxosmithkline Biolog Sa S tumorjem povezani antigenski derivati iz MAGE druĹľine in zaporedja nukleinskih kislin, ki jih kodirajo, uporabni za pripravo fuzijskih proteinov in sestavkov za cepljenje

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357421A (en) 1979-04-02 1982-11-02 G. D. Searle & Co. Synthetic gene coding for influenza hemagglutinin
IL61904A (en) * 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
ZA836080B (en) * 1982-08-23 1984-04-25 Scripps Clinic Res Broad spectrum influenza antisera
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit

Also Published As

Publication number Publication date
NO169819C (no) 1992-08-12
DK389085A (da) 1986-03-01
IE852103L (en) 1986-02-28
NO853400L (no) 1986-03-03
ZW13485A1 (en) 1985-11-20
DE3582843D1 (de) 1991-06-20
IE58488B1 (en) 1993-09-22
IL76236A0 (en) 1986-01-31
EP0176493A1 (en) 1986-04-02
FI853320L (fi) 1986-03-01
PT81061B (pt) 1987-11-11
FI85811C (fi) 1992-06-10
NZ213249A (en) 1989-03-29
FI853320A0 (fi) 1985-08-29
DK389085D0 (da) 1985-08-27
AU4668585A (en) 1986-03-06
ES8800358A1 (es) 1987-11-01
JPS6169731A (ja) 1986-04-10
KR860001882A (ko) 1986-03-24
HUT39362A (en) 1986-09-29
FI85811B (fi) 1992-02-28
ZA856467B (en) 1986-07-30
ES546530A0 (es) 1987-11-01
GR852079B (es) 1985-12-23
EP0176493B1 (en) 1991-05-15
PH27147A (en) 1993-04-02
HU196131B (en) 1988-10-28
PT81061A (en) 1985-09-01
AU592954B2 (en) 1990-02-01
NO169819B (no) 1992-05-04
ATE63462T1 (de) 1991-06-15

Similar Documents

Publication Publication Date Title
AR003425A1 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv)
PT677114E (pt) Virus da variola suina recombinante
DK11789D0 (da) Rekombinante vaccinia-vira
DK0538437T3 (da) Immunstimulerende og immunforstærkende, rekonstituerede influenzavirosomer og vacciner indeholdende dem
AR247590A1 (es) Una secuencia de adn que codifica derivados de factor viii humano recombinante y un procedimiento para su obtencion
CO5700784A2 (es) Polipeptidos de virus de papiloma humano y composiciones in- munogenas
AR067658A2 (es) Un polipeptido inmunogenico, un polinucleotido que lo codifica , las composiciones farmaceuticas que contienen dichos polipeptidos y polinucleotido, los vectores de xpresion, vacunas, un metodo para la preparacion de dicho polipeptido y una celula huesped aislada que expresa dicho polipeptido
DE69535018D1 (de) Papillomavirus vakzine
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
AR241713A1 (es) Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.
ES2127294T3 (es) Vacunas del virus de la inmunodeficiencia anti-felino (fiv).
ES8801372A1 (es) Un metodo para preparar una vacuna contra el virus de la influenza equina.
AR035077A1 (es) Polipeptidos de neublastina variante, proteinas de fusion, acidos nucleicos, vectores, celulas hospedadoras, metodos para producir dichos polipeptidos, dimeros, conjugados, composiciones farmaceuticas y uso de dichos polipeptidos en la preparacion de medicamentos
DE68925660D1 (de) Peptidfragmente von HIV
ES2039239T3 (es) Vacuna contra el virus varicela-zoster.
AR009365A1 (es) Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno
BR9204851A (pt) Antigeno de HIV e processo para sua produçao molécula de DNA recombinante, reagente para diagnóstico e vacina para sindrome da imunodeficiência adquirida
RU93048174A (ru) Авирулентная вакцина против бешенства и способ ее получения
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
MX9304349A (es) Vacuna antirrabica no virulenta.
DK0762895T3 (da) Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus
ES2063897T3 (es) Vacuna contra el virus del colera porcino y diagnostico.
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.
DK0541753T3 (da) Hidtil ukendt hybrid, opløselig og ikke-spaltelig gp160-variant
WO1993014206A3 (en) Synthetic peptides for a rubella vaccine